Suppr超能文献

蛋白酶体抑制诱导的皮质神经元包涵体形成和死亡需要转录和泛素化。

Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination.

作者信息

Rideout Hardy J, Stefanis Leonidas

机构信息

Department of Neurology, Columbia University, New York, New York 10032, USA.

出版信息

Mol Cell Neurosci. 2002 Oct;21(2):223-38. doi: 10.1006/mcne.2002.1173.

Abstract

Increasing evidence suggests that proteasomal dysfunction plays a role in the pathogenesis of Lewy body diseases. We have used pharmacological inhibitors of the proteasome to model proteasomal dysfunction in cultured rat cortical neurons. Proteasomal inhibition induced apoptotic death and formation of cytoplasmic ubiquitinated inclusions, which were present only in viable neurons. Actinomycin D, but not a caspase inhibitor, prevented inclusion formation, whereas both agents inhibited cell death. alpha-Synuclein and thioflavin S staining were found within the inclusions. alpha-Synuclein, however, did not appear to be ubiquitinated or aggregated. A dominant-negative mutant of an E2 ubiquitin-conjugating enzyme, cdc34, prevented inclusion formation and attenuated cell death. Our results suggest that in cortical neurons: (a) proteasomal dysfunction plays a role in formation of ubiquitin/alpha-synuclein-positive inclusions, (b) inclusion formation is an active cell process requiring transcription, and (c) ubiquitination of certain proteins is required for inclusion formation and may participate in neuronal death.

摘要

越来越多的证据表明,蛋白酶体功能障碍在路易体病的发病机制中起作用。我们已使用蛋白酶体的药理学抑制剂在培养的大鼠皮质神经元中模拟蛋白酶体功能障碍。蛋白酶体抑制诱导凋亡性死亡和细胞质泛素化包涵体的形成,这些包涵体仅存在于存活的神经元中。放线菌素D可阻止包涵体形成,但半胱天冬酶抑制剂则不能,而这两种药物均能抑制细胞死亡。在包涵体内发现了α-突触核蛋白和硫黄素S染色。然而,α-突触核蛋白似乎未被泛素化或聚集。E2泛素结合酶cdc34的显性负性突变体可阻止包涵体形成并减轻细胞死亡。我们的结果表明,在皮质神经元中:(a)蛋白酶体功能障碍在泛素/α-突触核蛋白阳性包涵体的形成中起作用;(b)包涵体形成是一个需要转录的活跃细胞过程;(c)某些蛋白质的泛素化是包涵体形成所必需的,并且可能参与神经元死亡。

相似文献

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验